Enhancing Transdiagnostic Mechanisms of Cognitive Dyscontrol (R33)
1 other identifier
interventional
128
1 country
1
Brief Summary
The proposed project aims to test the cognitive and neural effects of a cognitive training in a sample of individuals seeking treatment for anxiety, depression, or traumatic stress symptoms. Participants will be randomly assigned to one of two groups. Group 1 will receive a computer-based program that is designed as a cognitive training intervention and Group 2 will receive a similar computer-based exercise that researchers think will be less effective in training thinking skills (also known as a control or sham condition). Participants will be compared on cognitive performance and brain response during cognitive tasks from baseline to post-treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Oct 2024
Typical duration for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 31, 2024
CompletedFirst Posted
Study publicly available on registry
February 22, 2024
CompletedStudy Start
First participant enrolled
October 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2027
October 24, 2025
October 1, 2025
2.7 years
January 31, 2024
October 22, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change in cognitive performance
Span Working Memory Score. Scores are calculated based on memory accuracy total points across all trials, with higher scores indicating better performance. This change is expected to be significantly higher for the COGENT group than the Sham group.
Baseline, Week 4, Week 8, Week 16
Secondary Outcomes (3)
Reading Span Blood Oxygen Level Dependent (BOLD) Response
Baseline, Week 4
Neuropsychological Performance
Baseline, Week 4, Week 8, Week 16
Repetitive Negative Thinking (RNT)
Baseline, Week 4,Week 8, Week 16
Other Outcomes (7)
Disability
Baseline, Week 4,Week 8, Week 16
Suicide Cognitions
Baseline, Week 4,Week 8, Week 16
Mood and Emotions
Baseline, Week 4,Week 8, Week 16
- +4 more other outcomes
Study Arms (2)
COGENT - Cognitive Training Intervention Program
EXPERIMENTALComputer-administered cognitive training program. COGENT is a modified working memory capacity task designed to train cognitive functioning. COGENT was designed to contain high interference across trials. By requiring repeated practice with utilization of interference control across trials, COGENT is thought to enhance plasticity of cognitive systems and improve performance. That is, training is based on the premise that learning-based neural changes will occur via repeated exposure to a task demanding cognitive control resources
Non-Training Program
SHAM COMPARATORThe non-training condition requires participants to complete a similar computer task for the same length of time. The non-training is a modified working memory capacity task designed to be inert. The non-training condition was designed to contain relatively less interference demands across trials.
Interventions
COGENT is based on a working memory capacity task, which requires individuals to memorize stimuli while simultaneously completing a secondary puzzle task.
The Sham Program will be a similar task which researchers think will be less effective in training thinking skills.
Eligibility Criteria
You may qualify if:
- age 21-55
- fluent in English
- diagnosis of mood, anxiety, or traumatic stress disorder
- clinically elevated repetitive negative thinking
- outpatient status
- week stability if taking selective serotonin reuptake inhibitor (SSRI) medications
You may not qualify if:
- past year diagnosis of severe alcohol or moderate or greater substance use disorder
- lifetime history of psychotic or bipolar I disorder
- acute suicidality necessitating immediate clinical intervention
- neurodegenerative or neurodevelopmental disorders
- history of moderate or severe traumatic brain injury or other known neurological condition
- sensory deficits that would preclude completing tasks
- conditions unsafe for completing MRI scanning (e.g., metal in body)
- current pregnancy
- currently receiving psychosocial treatment
- currently receiving psychiatric pharmacotherapy, except SSRIs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UC San Diego
San Diego, California, 92037, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
January 31, 2024
First Posted
February 22, 2024
Study Start
October 1, 2024
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
August 1, 2027
Last Updated
October 24, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share